Sabine Hoff

638 total citations
8 papers, 434 citations indexed

About

Sabine Hoff is a scholar working on Oncology, Immunology and Dermatology. According to data from OpenAlex, Sabine Hoff has authored 8 papers receiving a total of 434 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 6 papers in Immunology and 2 papers in Dermatology. Recurrent topics in Sabine Hoff's work include Immunotherapy and Immune Responses (3 papers), Cancer Immunotherapy and Biomarkers (3 papers) and CAR-T cell therapy research (2 papers). Sabine Hoff is often cited by papers focused on Immunotherapy and Immune Responses (3 papers), Cancer Immunotherapy and Biomarkers (3 papers) and CAR-T cell therapy research (2 papers). Sabine Hoff collaborates with scholars based in Germany, United States and Netherlands. Sabine Hoff's co-authors include Frederik Barkhof, Chris H. Polman, Bob W. van Oosten, Anette H.H. van Boxel-Dezaire, Lex Nagelkerken, Hans C. van Houwelingen, H.J. Adèr, C. L. Verweij, Dieter Zopf and Anne Rix and has published in prestigious journals such as The Journal of Experimental Medicine, Cancer Research and Annals of Neurology.

In The Last Decade

Sabine Hoff

7 papers receiving 425 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sabine Hoff Germany	5	222	163	163	66	57	8	434
Rachel Cant United Kingdom	6	159 0.7×	199 1.2×	57 0.3×	53 0.8×	72 1.3×	6	479
Yosuke Ishitsuka Japan	12	129 0.6×	31 0.2×	147 0.9×	94 1.4×	117 2.1×	34	443
Atrin Toussi United States	9	87 0.4×	51 0.3×	66 0.4×	38 0.6×	173 3.0×	23	417
Qixing Gong China	11	49 0.2×	171 1.0×	163 1.0×	40 0.6×	28 0.5×	30	316
Annemarie L Dorjée Netherlands	12	278 1.3×	77 0.5×	39 0.2×	280 4.2×	38 0.7×	19	560
Nikolaos Patsinakidis Germany	10	165 0.7×	93 0.6×	24 0.1×	262 4.0×	138 2.4×	19	410
Isamu Kingetsu Japan	11	93 0.4×	28 0.2×	32 0.2×	102 1.5×	37 0.6×	24	355
M Fukayama Japan	10	75 0.3×	83 0.5×	55 0.3×	30 0.5×	35 0.6×	23	347
Xiaolan Tian China	11	126 0.6×	40 0.2×	21 0.1×	170 2.6×	60 1.1×	23	375
Emi Nishimagi Japan	8	120 0.5×	218 1.3×	19 0.1×	49 0.7×	81 1.4×	13	360

Countries citing papers authored by Sabine Hoff

Since Specialization

Citations

This map shows the geographic impact of Sabine Hoff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sabine Hoff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sabine Hoff more than expected).

Fields of papers citing papers by Sabine Hoff

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sabine Hoff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sabine Hoff. The network helps show where Sabine Hoff may publish in the future.

Co-authorship network of co-authors of Sabine Hoff

This figure shows the co-authorship network connecting the top 25 collaborators of Sabine Hoff. A scholar is included among the top collaborators of Sabine Hoff based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sabine Hoff. Sabine Hoff is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

Roider, Helge G., Sabine Hoff, Su-Yi Tseng, et al.. (2024). Selective depletion of tumor-infiltrating regulatory T cells with BAY 3375968, a novel Fc-optimized anti-CCR8 antibody. Clinical and Experimental Medicine. 24(1). 122–122. 10 indexed citations

Roider, Helge G., Su-Yi Tseng, Sabine Hoff, et al.. (2022). Abstract 2866: BAY 3375968: An afucosylated anti-CCR8 antibody depleting activated intratumoral regulatory T cells as a cancer immunotherapy. Cancer Research. 82(12_Supplement). 2866–2866. 1 indexed citations

Doleschel, Dennis, Sabine Hoff, Anne Rix, et al.. (2021). Regorafenib enhances anti-PD1 immunotherapy efficacy in murine colorectal cancers and their combination prevents tumor regrowth. Journal of Experimental & Clinical Cancer Research. 40(1). 288–288. 80 indexed citations

Sommer, Anette, Pascale Lejeune, Sabine Hoff, et al.. (2019). Abstract 4816: Anetumab ravtansine has monotherapy efficacy in mesothelin positive patient-derived NSCLC tumor models and in a syngeneic tumor model in immunocompetent mice. Cancer Research. 79(13_Supplement). 4816–4816. 1 indexed citations

Hoff, Sabine, Michiko K. Oyoshi, Jason L. Hornick, & Raif S. Geha. (2018). MyD88 signaling in T regulatory cells by endogenous ligands dampens skin inflammation in filaggrin deficient mice. Clinical Immunology. 195. 88–92.

Hoff, Sabine, Sylvia Grünewald, Lars Röse, & Dieter Zopf. (2017). Immunomodulation by regorafenib alone and in combination with anti PD1 antibody on murine models of colorectal cancer. Annals of Oncology. 28. v423–v423. 40 indexed citations

Yoon, Juhan, Juan Manuel Leyva-Castillo, Guoxing Wang, et al.. (2016). IL-23 induced in keratinocytes by endogenous TLR4 ligands polarizes dendritic cells to drive IL-22 responses to skin immunization. The Journal of Experimental Medicine. 213(10). 2147–2166. 80 indexed citations

Boxel-Dezaire, Anette H.H. van, Sabine Hoff, Bob W. van Oosten, et al.. (1999). Decreased interleukin-10 and increased interleukin-12p40 mRNA are associated with disease activity and characterize different disease stages in multiple sclerosis. Annals of Neurology. 45(6). 695–703. 222 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact